Pfizer, US Ink $5.29B Deal For Possible COVID-19 Treatment

This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP)

The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it. Pfizer asked U.S. regulators on Tuesday to authorize emergency use of its experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with COVID-19. Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms. The Food and Drug Administration is already reviewing a competing pill from Merck and will hold a public meeting on it later this month.


Deere Workers Approve 3rd Contract Offer, Will End Strike

Previous article

Cameron County Hits Grim COVID Milestone

Next article

You may also like